A detailed history of Great West Life Assurance CO transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 53,514 shares of AUPH stock, worth $402,425. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,514
Previous 53,514 -0.0%
Holding current value
$402,425
Previous $268,000 13.81%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$7.13 - $9.49 $117,317 - $156,148
16,454 Added 44.4%
53,514 $479,000
Q3 2023

Nov 14, 2023

BUY
$7.77 - $12.27 $237,194 - $374,566
30,527 Added 467.27%
37,060 $288,000
Q3 2022

Nov 01, 2022

BUY
$6.66 - $12.39 $43,509 - $80,943
6,533 New
6,533 $49,000
Q1 2022

May 12, 2022

BUY
$10.05 - $22.48 $11,979 - $26,796
1,192 Added 22.32%
6,533 $86,000
Q4 2021

Feb 14, 2022

SELL
$17.78 - $33.08 $2,471 - $4,598
-139 Reduced 2.54%
5,341 $122,000
Q2 2021

Aug 11, 2021

SELL
$10.0 - $14.52 $19,310 - $28,038
-1,931 Reduced 26.06%
5,480 $71,000
Q1 2021

May 17, 2021

SELL
$12.3 - $18.73 $63,541 - $96,759
-5,166 Reduced 41.07%
7,411 $95,000
Q4 2020

Feb 16, 2021

SELL
$12.94 - $16.05 $1,358 - $1,685
-105 Reduced 0.83%
12,577 $174,000
Q3 2020

Nov 17, 2020

SELL
$13.19 - $16.66 $512,009 - $646,707
-38,818 Reduced 75.37%
12,682 $186,000
Q3 2020

Nov 13, 2020

BUY
$13.19 - $16.66 $521,756 - $659,019
39,557 Added 331.21%
51,500 $758,000
Q2 2020

Aug 17, 2020

BUY
$14.12 - $18.33 $118,212 - $153,458
8,372 Added 234.44%
11,943 $193,000
Q4 2019

Feb 11, 2020

BUY
$3.88 - $21.42 $13,855 - $76,490
3,571 New
3,571 $72,000
Q3 2019

Oct 25, 2019

SELL
$5.34 - $6.59 $35,938 - $44,350
-6,730 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$4.53 - $7.09 $30,486 - $47,715
6,730
6,730 $31,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.07B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.